Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings Download PDF Antoine Balavoine2024-02-02T15:10:11+01:00February 2nd, 2024|Press Releases|
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024 Download PDF Antoine Balavoine2024-01-17T17:11:22+01:00January 17th, 2024|Press Releases|
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings Download PDF Antoine Balavoine2024-01-17T14:27:34+01:00January 17th, 2024|Press Releases|
Information on total number of voting rights and shares composing the share capital as at December 31, 2023 Download PDF Antoine Balavoine2024-01-05T19:03:06+01:00January 5th, 2024|Other Regulated Information|
Information on total number of voting rights and shares composing the share capital as at November 30, 2023 Download PDF Antoine Balavoine2023-12-07T17:47:36+01:00December 7th, 2023|Other Regulated Information|
Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023 Download PDF Antoine Balavoine2023-12-05T11:13:18+01:00December 4th, 2023|Press Releases|
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Download PDF Antoine Balavoine2023-11-20T18:57:16+01:00November 20th, 2023|Press Releases|
OCA follow-up – Situation on November 15, 2023 Download PDF Antoine Balavoine2023-11-15T09:24:08+01:00November 15th, 2023|Other Regulated Information|
OCA follow-up – Situation on November 14, 2023 Download PDF Antoine Balavoine2023-11-14T14:04:08+01:00November 14th, 2023|Other Regulated Information|
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Download PDF Antoine Balavoine2023-11-14T08:33:30+01:00November 14th, 2023|Press Releases|